- call +1-201-465-4211
- email sales@mrinsights.biz
According to this latest study, the 2021 growth of Biologics and Biosimilars will have significant change from previous year. By the most conservative estimates of global Biologics and Biosimilars market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 292500 million in 2020. Over the next five years the Biologics and Biosimilars market will register a 8.2% CAGR in terms of revenue, the global market size will reach US$ 400820 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Biologics and Biosimilars market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Monoclonal Antibodies
Interferon
Erythropoietin
Insulin
Vaccines
Others
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Tumor
Diabetes
Cardiovascular
Hemophilia
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biologics and Biosimilars Consumption 2016-2026
2.1.2 Biologics and Biosimilars Consumption CAGR by Region
2.2 Biologics and Biosimilars Segment by Type
2.2.1 Monoclonal Antibodies
2.2.2 Interferon
2.2.3 Erythropoietin
2.2.4 Insulin
2.2.5 Vaccines
2.2.6 Others
2.3 Biologics and Biosimilars Sales by Type
2.3.1 Global Biologics and Biosimilars Sales Market Share by Type (2016-2021)
2.3.2 Global Biologics and Biosimilars Revenue and Market Share by Type (2016-2021)
2.3.3 Global Biologics and Biosimilars Sale Price by Type (2016-2021)
2.4 Biologics and Biosimilars Segment by Application
2.4.1 Tumor
2.4.2 Diabetes
2.4.3 Cardiovascular
2.4.4 Hemophilia
2.4.5 Others
2.5 Biologics and Biosimilars Sales by Application
2.5.1 Global Biologics and Biosimilars Sale Market Share by Application (2016-2021)
2.5.2 Global Biologics and Biosimilars Revenue and Market Share by Application (2016-2021)
2.5.3 Global Biologics and Biosimilars Sale Price by Application (2016-2021)
3 Global Biologics and Biosimilars by Company
3.1 Global Biologics and Biosimilars Sales Market Share by Company
3.1.1 Global Biologics and Biosimilars Sales by Company (2019-2021)
3.1.2 Global Biologics and Biosimilars Sales Market Share by Company (2019-2021)
3.2 Global Biologics and Biosimilars Revenue Market Share by Company
3.2.1 Global Biologics and Biosimilars Revenue by Company (2019-2021)
3.2.2 Global Biologics and Biosimilars Revenue Market Share by Company (2019-2021)
3.3 Global Biologics and Biosimilars Sale Price by Company
3.4 Global Manufacturers Biologics and Biosimilars Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Biologics and Biosimilars Product Location Distribution
3.4.2 Players Biologics and Biosimilars Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Biologics and Biosimilars by Region
4.1 Global Biologics and Biosimilars by Region
4.1.1 Global Biologics and Biosimilars Sales by Region
4.1.2 Global Biologics and Biosimilars Revenue by Region
4.2 Americas Biologics and Biosimilars Sales Growth
4.3 APAC Biologics and Biosimilars Sales Growth
4.4 Europe Biologics and Biosimilars Sales Growth
4.5 Middle East & Africa Biologics and Biosimilars Sales Growth
5 Americas
5.1 Americas Biologics and Biosimilars Sales by Country
5.1.1 Americas Biologics and Biosimilars Sales by Country (2016-2021)
5.1.2 Americas Biologics and Biosimilars Revenue by Country (2016-2021)
5.2 Americas Biologics and Biosimilars Sales by Type
5.3 Americas Biologics and Biosimilars Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biologics and Biosimilars Sales by Region
6.1.1 APAC Biologics and Biosimilars Sales by Region (2016-2021)
6.1.2 APAC Biologics and Biosimilars Revenue by Region (2016-2021)
6.2 APAC Biologics and Biosimilars Sales by Type
6.3 APAC Biologics and Biosimilars Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Biologics and Biosimilars by Country
7.1.1 Europe Biologics and Biosimilars Sales by Country (2016-2021)
7.1.2 Europe Biologics and Biosimilars Revenue by Country (2016-2021)
7.2 Europe Biologics and Biosimilars Sales by Type
7.3 Europe Biologics and Biosimilars Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Biologics and Biosimilars by Country
8.1.1 Middle East & Africa Biologics and Biosimilars Sales by Country (2016-2021)
8.1.2 Middle East & Africa Biologics and Biosimilars Revenue by Country (2016-2021)
8.2 Middle East & Africa Biologics and Biosimilars Sales by Type
8.3 Middle East & Africa Biologics and Biosimilars Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Biologics and Biosimilars Distributors
10.3 Biologics and Biosimilars Customer
11 Global Biologics and Biosimilars Market Forecast
11.1 Global Biologics and Biosimilars Forecast by Region
11.1.1 Global Biologics and Biosimilars Forecast by Regions (2021-2026)
11.2.2 Global Biologics and Biosimilars Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Biologics and Biosimilars Forecast by Type
11.7 Global Biologics and Biosimilars Forecast by Application
12 Key Players Analysis
12.1 Roche
12.1.1 Roche Company Information
12.1.2 Roche Biologics and Biosimilars Product Offered
12.1.3 Roche Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Roche Main Business Overview
12.1.5 Roche Latest Developments
12.2 Amgen
12.2.1 Amgen Company Information
12.2.2 Amgen Biologics and Biosimilars Product Offered
12.2.3 Amgen Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Amgen Main Business Overview
12.2.5 Amgen Latest Developments
12.3 AbbVie
12.3.1 AbbVie Company Information
12.3.2 AbbVie Biologics and Biosimilars Product Offered
12.3.3 AbbVie Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 AbbVie Main Business Overview
12.3.5 AbbVie Latest Developments
12.4 Sanofi-Aventis
12.4.1 Sanofi-Aventis Company Information
12.4.2 Sanofi-Aventis Biologics and Biosimilars Product Offered
12.4.3 Sanofi-Aventis Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Sanofi-Aventis Main Business Overview
12.4.5 Sanofi-Aventis Latest Developments
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Company Information
12.5.2 Johnson & Johnson Biologics and Biosimilars Product Offered
12.5.3 Johnson & Johnson Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Johnson & Johnson Main Business Overview
12.5.5 Johnson & Johnson Latest Developments
12.6 Pfizer
12.6.1 Pfizer Company Information
12.6.2 Pfizer Biologics and Biosimilars Product Offered
12.6.3 Pfizer Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Pfizer Main Business Overview
12.6.5 Pfizer Latest Developments
12.7 Novo Nordisk
12.7.1 Novo Nordisk Company Information
12.7.2 Novo Nordisk Biologics and Biosimilars Product Offered
12.7.3 Novo Nordisk Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Novo Nordisk Main Business Overview
12.7.5 Novo Nordisk Latest Developments
12.8 Eli Lilly
12.8.1 Eli Lilly Company Information
12.8.2 Eli Lilly Biologics and Biosimilars Product Offered
12.8.3 Eli Lilly Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Eli Lilly Main Business Overview
12.8.5 Eli Lilly Latest Developments
12.9 Novartis
12.9.1 Novartis Company Information
12.9.2 Novartis Biologics and Biosimilars Product Offered
12.9.3 Novartis Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Novartis Main Business Overview
12.9.5 Novartis Latest Developments
12.10 Merck
12.10.1 Merck Company Information
12.10.2 Merck Biologics and Biosimilars Product Offered
12.10.3 Merck Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Merck Main Business Overview
12.10.5 Merck Latest Developments
12.11 3sbio
12.11.1 3sbio Company Information
12.11.2 3sbio Biologics and Biosimilars Product Offered
12.11.3 3sbio Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 3sbio Main Business Overview
12.11.5 3sbio Latest Developments
12.12 Changchun High Tech
12.12.1 Changchun High Tech Company Information
12.12.2 Changchun High Tech Biologics and Biosimilars Product Offered
12.12.3 Changchun High Tech Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Changchun High Tech Main Business Overview
12.12.5 Changchun High Tech Latest Developments
12.13 CP Guojian
12.13.1 CP Guojian Company Information
12.13.2 CP Guojian Biologics and Biosimilars Product Offered
12.13.3 CP Guojian Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 CP Guojian Main Business Overview
12.13.5 CP Guojian Latest Developments
12.14 Biotech
12.14.1 Biotech Company Information
12.14.2 Biotech Biologics and Biosimilars Product Offered
12.14.3 Biotech Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Biotech Main Business Overview
12.14.5 Biotech Latest Developments
12.15 Gelgen
12.15.1 Gelgen Company Information
12.15.2 Gelgen Biologics and Biosimilars Product Offered
12.15.3 Gelgen Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Gelgen Main Business Overview
12.15.5 Gelgen Latest Developments
12.16 Innovent
12.16.1 Innovent Company Information
12.16.2 Innovent Biologics and Biosimilars Product Offered
12.16.3 Innovent Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 Innovent Main Business Overview
12.16.5 Innovent Latest Developments
12.17 Dong Bao
12.17.1 Dong Bao Company Information
12.17.2 Dong Bao Biologics and Biosimilars Product Offered
12.17.3 Dong Bao Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2019-2021)
12.17.4 Dong Bao Main Business Overview
12.17.5 Dong Bao Latest Developments
12.18 Ganlee
12.18.1 Ganlee Company Information
12.18.2 Ganlee Biologics and Biosimilars Product Offered
12.18.3 Ganlee Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2019-2021)
12.18.4 Ganlee Main Business Overview
12.18.5 Ganlee Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Biologics and Biosimilars Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Monoclonal Antibodies
Table 3. Major Players of Interferon
Table 4. Major Players of Erythropoietin
Table 5. Major Players of Insulin
Table 6. Major Players of Vaccines
Table 7. Major Players of Others
Table 8. Global Biologics and Biosimilars Sales by Type (2016-2021) & (K Units)
Table 9. Global Biologics and Biosimilars Sales Market Share by Type (2016-2021)
Table 10. Global Biologics and Biosimilars Revenue by Type (2016-2021) & ($ million)
Table 11. Global Biologics and Biosimilars Revenue Market Share by Type (2016-2021)
Table 12. Global Biologics and Biosimilars Sale Price by Type (2016-2021)
Table 13. Global Biologics and Biosimilars Sales by Application (2016-2021) & (K Units)
Table 14. Global Biologics and Biosimilars Sales Market Share by Application (2016-2021)
Table 15. Global Biologics and Biosimilars Value by Application (2016-2021)
Table 16. Global Biologics and Biosimilars Revenue Market Share by Application (2016-2021)
Table 17. Global Biologics and Biosimilars Sale Price by Application (2016-2021)
Table 18. Global Biologics and Biosimilars Sales by Company (2019-2021) & (K Units)
Table 19. Global Biologics and Biosimilars Sales Market Share by Company (2019-2021)
Table 20. Global Biologics and Biosimilars Revenue by Company (2019-2021) ($ Millions)
Table 21. Global Biologics and Biosimilars Revenue Market Share by Company (2019-2021)
Table 22. Global Biologics and Biosimilars Sale Price by Company (2019-2021)
Table 23. Key Manufacturers Biologics and Biosimilars Producing Area Distribution and Sales Area
Table 24. Players Biologics and Biosimilars Products Offered
Table 25. Biologics and Biosimilars Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Biologics and Biosimilars Sales by Region (2016-2021) (K Units)
Table 29. Global Biologics and Biosimilars Sales Market Share by Region (2016-2021)
Table 30. Global Biologics and Biosimilars Revenue by Region (2016-2021) & ($ Millions)
Table 31. Global Biologics and Biosimilars Revenue Market Share by Region (2016-2021)
Table 32. Americas Biologics and Biosimilars Sales by Country (2016-2021) & (K Units)
Table 33. Americas Biologics and Biosimilars Sales Market Share by Country (2016-2021)
Table 34. Americas Biologics and Biosimilars Revenue by Country (2016-2021) & ($ Millions)
Table 35. Americas Biologics and Biosimilars Revenue Market Share by Country (2016-2021)
Table 36. Americas Biologics and Biosimilars Sales by Type (2016-2021) & (K Units)
Table 37. Americas Biologics and Biosimilars Sales Market Share by Type (2016-2021)
Table 38. Americas Biologics and Biosimilars Sales by Application (2016-2021) & (K Units)
Table 39. Americas Biologics and Biosimilars Sales Market Share by Application (2016-2021)
Table 40. APAC Biologics and Biosimilars Sales by Region (2016-2021) & (K Units)
Table 41. APAC Biologics and Biosimilars Sales Market Share by Region (2016-2021)
Table 42. APAC Biologics and Biosimilars Revenue by Region (2016-2021) & ($ Millions)
Table 43. APAC Biologics and Biosimilars Revenue Market Share by Region (2016-2021)
Table 44. APAC Biologics and Biosimilars Sales by Type (2016-2021) & (K Units)
Table 45. APAC Biologics and Biosimilars Sales Market Share by Type (2016-2021)
Table 46. APAC Biologics and Biosimilars Sales by Application (2016-2021) & (K Units)
Table 47. APAC Biologics and Biosimilars Sales Market Share by Application (2016-2021)
Table 48. Europe Biologics and Biosimilars Sales by Country (2016-2021) & (K Units)
Table 49. Europe Biologics and Biosimilars Sales Market Share by Country (2016-2021)
Table 50. Europe Biologics and Biosimilars Revenue by Country (2016-2021) & ($ Millions)
Table 51. Europe Biologics and Biosimilars Revenue Market Share by Country (2016-2021)
Table 52. Europe Biologics and Biosimilars Sales by Type (2016-2021) & (K Units)
Table 53. Europe Biologics and Biosimilars Sales Market Share by Type (2016-2021)
Table 54. Europe Biologics and Biosimilars Sales by Application (2016-2021) & (K Units)
Table 55. Europe Biologics and Biosimilars Sales Market Share by Application (2016-2021)
Table 56. Middle East & Africa Biologics and Biosimilars Sales by Country (2016-2021) & (K Units)
Table 57. Middle East & Africa Biologics and Biosimilars Sales Market Share by Country (2016-2021)
Table 58. Middle East & Africa Biologics and Biosimilars Revenue by Country (2016-2021) & ($ Millions)
Table 59. Middle East & Africa Biologics and Biosimilars Revenue Market Share by Country (2016-2021)
Table 60. Middle East & Africa Biologics and Biosimilars Sales by Type (2016-2021) & (K Units)
Table 61. Middle East & Africa Biologics and Biosimilars Sales Market Share by Type (2016-2021)
Table 62. Middle East & Africa Biologics and Biosimilars Sales by Application (2016-2021) & (K Units)
Table 63. Middle East & Africa Biologics and Biosimilars Sales Market Share by Application (2016-2021)
Table 64. Key and Potential Regions of Biologics and Biosimilars
Table 65. Key Application and Potential Industries of Biologics and Biosimilars
Table 66. Key Challenges of Biologics and Biosimilars
Table 67. Key Trends of Biologics and Biosimilars
Table 68. Biologics and Biosimilars Distributors List
Table 69. Biologics and Biosimilars Customer List
Table 70. Global Biologics and Biosimilars Sales Forecast by Region (2021-2026) & (K Units)
Table 71. Global Biologics and Biosimilars Consumption Market Forecast by Region
Table 72. Global Biologics and Biosimilars Revenue Forecast by Region (2021-2026) & ($ millions)
Table 73. Global Biologics and Biosimilars Revenue Market Share Forecast by Region (2021-2026)
Table 74. Americas Biologics and Biosimilars Sales Forecast by Country (2021-2026) & (K Units)
Table 75. Americas Biologics and Biosimilars Revenue Forecast by Country (2021-2026) & ($ millions)
Table 76. APAC Biologics and Biosimilars Sales Forecast by Region (2021-2026) & (K Units)
Table 77. APAC Biologics and Biosimilars Revenue Forecast by Region (2021-2026) & ($ millions)
Table 78. Europe Biologics and Biosimilars Sales Forecast by Country (2021-2026) & (K Units)
Table 79. Europe Biologics and Biosimilars Revenue Forecast by Country (2021-2026) & ($ millions)
Table 80. Middle East & Africa Biologics and Biosimilars Sales Forecast by Country (2021-2026) & (K Units)
Table 81. Middle East & Africa Biologics and Biosimilars Revenue Forecast by Country (2021-2026) & ($ millions)
Table 82. Global Biologics and Biosimilars Sales Forecast by Type (2021-2026) & (K Units)
Table 83. Global Biologics and Biosimilars Sales Market Share Forecast by Type (2021-2026)
Table 84. Global Biologics and Biosimilars Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 85. Global Biologics and Biosimilars Revenue Market Share Forecast by Type (2021-2026)
Table 86. Global Biologics and Biosimilars Sales Forecast by Application (2021-2026) & (K Units)
Table 87. Global Biologics and Biosimilars Sales Market Share Forecast by Application (2021-2026)
Table 88. Global Biologics and Biosimilars Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 89. Global Biologics and Biosimilars Revenue Market Share Forecast by Application (2021-2026)
Table 90. Roche Basic Information, Biologics and Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 91. Roche Biologics and Biosimilars Product Offered
Table 92. Roche Biologics and Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 93. Roche Main Business
Table 94. Roche Latest Developments
Table 95. Amgen Basic Information, Biologics and Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 96. Amgen Biologics and Biosimilars Product Offered
Table 97. Amgen Biologics and Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 98. Amgen Main Business
Table 99. Amgen Latest Developments
Table 100. AbbVie Basic Information, Biologics and Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 101. AbbVie Biologics and Biosimilars Product Offered
Table 102. AbbVie Biologics and Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 103. AbbVie Main Business
Table 104. AbbVie Latest Developments
Table 105. Sanofi-Aventis Basic Information, Biologics and Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 106. Sanofi-Aventis Biologics and Biosimilars Product Offered
Table 107. Sanofi-Aventis Biologics and Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 108. Sanofi-Aventis Main Business
Table 109. Sanofi-Aventis Latest Developments
Table 110. Johnson & Johnson Basic Information, Biologics and Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 111. Johnson & Johnson Biologics and Biosimilars Product Offered
Table 112. Johnson & Johnson Biologics and Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 113. Johnson & Johnson Main Business
Table 114. Johnson & Johnson Latest Developments
Table 115. Pfizer Basic Information, Biologics and Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 116. Pfizer Biologics and Biosimilars Product Offered
Table 117. Pfizer Biologics and Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 118. Pfizer Main Business
Table 119. Pfizer Latest Developments
Table 120. Novo Nordisk Basic Information, Biologics and Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 121. Novo Nordisk Biologics and Biosimilars Product Offered
Table 122. Novo Nordisk Biologics and Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 123. Novo Nordisk Main Business
Table 124. Novo Nordisk Latest Developments
Table 125. Eli Lilly Basic Information, Biologics and Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 126. Eli Lilly Biologics and Biosimilars Product Offered
Table 127. Eli Lilly Biologics and Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 128. Eli Lilly Main Business
Table 129. Eli Lilly Latest Developments
Table 130. Novartis Basic Information, Biologics and Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 131. Novartis Biologics and Biosimilars Product Offered
Table 132. Novartis Biologics and Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 133. Novartis Main Business
Table 134. Novartis Latest Developments
Table 135. Merck Basic Information, Biologics and Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 136. Merck Biologics and Biosimilars Product Offered
Table 137. Merck Biologics and Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 138. Merck Main Business
Table 139. Merck Latest Developments
Table 140. 3sbio Basic Information, Biologics and Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 141. 3sbio Biologics and Biosimilars Product Offered
Table 142. 3sbio Biologics and Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 143. 3sbio Main Business
Table 144. 3sbio Latest Developments
Table 145. Changchun High Tech Basic Information, Biologics and Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 146. Changchun High Tech Biologics and Biosimilars Product Offered
Table 147. Changchun High Tech Biologics and Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 148. Changchun High Tech Main Business
Table 149. Changchun High Tech Latest Developments
Table 150. CP Guojian Basic Information, Biologics and Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 151. CP Guojian Biologics and Biosimilars Product Offered
Table 152. CP Guojian Biologics and Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 153. CP Guojian Main Business
Table 154. CP Guojian Latest Developments
Table 155. Biotech Basic Information, Biologics and Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 156. Biotech Biologics and Biosimilars Product Offered
Table 157. Biotech Biologics and Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 158. Biotech Main Business
Table 159. Biotech Latest Developments
Table 160. Gelgen Basic Information, Biologics and Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 161. Gelgen Biologics and Biosimilars Product Offered
Table 162. Gelgen Biologics and Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 163. Gelgen Main Business
Table 164. Gelgen Latest Developments
Table 165. Innovent Basic Information, Biologics and Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 166. Innovent Biologics and Biosimilars Product Offered
Table 167. Innovent Biologics and Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 168. Innovent Main Business
Table 169. Innovent Latest Developments
Table 170. Dong Bao Basic Information, Biologics and Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 171. Dong Bao Biologics and Biosimilars Product Offered
Table 172. Dong Bao Biologics and Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 173. Dong Bao Main Business
Table 174. Dong Bao Latest Developments
Table 175. Ganlee Basic Information, Biologics and Biosimilars Manufacturing Base, Sales Area and Its Competitors
Table 176. Ganlee Biologics and Biosimilars Product Offered
Table 177. Ganlee Biologics and Biosimilars Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 178. Ganlee Main Business
Table 179. Ganlee Latest Developments
List of Figures
Figure 1. Picture of Biologics and Biosimilars
Figure 2. Biologics and Biosimilars Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Biologics and Biosimilars Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Biologics and Biosimilars Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Biologics and Biosimilars Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Monoclonal Antibodies
Figure 10. Product Picture of Interferon
Figure 11. Product Picture of Erythropoietin
Figure 12. Product Picture of Insulin
Figure 13. Product Picture of Vaccines
Figure 14. Product Picture of Others
Figure 15. Global Biologics and Biosimilars Sales Market Share by Type in 2020
Figure 16. Global Biologics and Biosimilars Revenue Market Share by Type (2016-2021)
Figure 17. Biologics and Biosimilars Consumed in Tumor
Figure 18. Global Biologics and Biosimilars Market: Tumor (2016-2021) & (K Units)
Figure 19. Biologics and Biosimilars Consumed in Diabetes
Figure 20. Global Biologics and Biosimilars Market: Diabetes (2016-2021) & (K Units)
Figure 21. Biologics and Biosimilars Consumed in Cardiovascular
Figure 22. Global Biologics and Biosimilars Market: Cardiovascular (2016-2021) & (K Units)
Figure 23. Biologics and Biosimilars Consumed in Hemophilia
Figure 24. Global Biologics and Biosimilars Market: Hemophilia (2016-2021) & (K Units)
Figure 25. Biologics and Biosimilars Consumed in Others
Figure 26. Global Biologics and Biosimilars Market: Others (2016-2021) & (K Units)
Figure 27. Global Biologics and Biosimilars Sales Market Share by Application (2016-2021)
Figure 28. Global Biologics and Biosimilars Revenue Market Share by Application in 2020
Figure 29. Biologics and Biosimilars Revenue Market by Company in 2020 ($ Million)
Figure 30. Global Biologics and Biosimilars Revenue Market Share by Company in 2020
Figure 31. Global Biologics and Biosimilars Sales Market Share by Regions (2016-2021)
Figure 32. Global Biologics and Biosimilars Revenue Market Share by Region in 2020
Figure 33. Americas Biologics and Biosimilars Sales 2016-2021 (K Units)
Figure 34. Americas Biologics and Biosimilars Revenue 2016-2021 ($ Millions)
Figure 35. APAC Biologics and Biosimilars Sales 2016-2021 (K Units)
Figure 36. APAC Biologics and Biosimilars Revenue 2016-2021 ($ Millions)
Figure 37. Europe Biologics and Biosimilars Sales 2016-2021 (K Units)
Figure 38. Europe Biologics and Biosimilars Revenue 2016-2021 ($ Millions)
Figure 39. Middle East & Africa Biologics and Biosimilars Sales 2016-2021 (K Units)
Figure 40. Middle East & Africa Biologics and Biosimilars Revenue 2016-2021 ($ Millions)
Figure 41. Americas Biologics and Biosimilars Sales Market Share by Country in 2020
Figure 42. Americas Biologics and Biosimilars Revenue Market Share by Country in 2020
Figure 43. Americas Biologics and Biosimilars Sales Market Share by Type in 2020
Figure 44. Americas Biologics and Biosimilars Sales Market Share by Application in 2020
Figure 45. United States Biologics and Biosimilars Revenue Growth 2016-2021 ($ Millions)
Figure 46. Canada Biologics and Biosimilars Revenue Growth 2016-2021 ($ Millions)
Figure 47. Mexico Biologics and Biosimilars Revenue Growth 2016-2021 ($ Millions)
Figure 48. Brazil Biologics and Biosimilars Revenue Growth 2016-2021 ($ Millions)
Figure 49. APAC Biologics and Biosimilars Sales Market Share by Region in 2020
Figure 50. APAC Biologics and Biosimilars Revenue Market Share by Regions in 2020
Figure 51. APAC Biologics and Biosimilars Sales Market Share by Type in 2020
Figure 52. APAC Biologics and Biosimilars Sales Market Share by Application in 2020
Figure 53. China Biologics and Biosimilars Revenue Growth 2016-2021 ($ Millions)
Figure 54. Japan Biologics and Biosimilars Revenue Growth 2016-2021 ($ Millions)
Figure 55. Korea Biologics and Biosimilars Revenue Growth 2016-2021 ($ Millions)
Figure 56. Southeast Asia Biologics and Biosimilars Revenue Growth 2016-2021 ($ Millions)
Figure 57. India Biologics and Biosimilars Revenue Growth 2016-2021 ($ Millions)
Figure 58. Australia Biologics and Biosimilars Revenue Growth 2016-2021 ($ Millions)
Figure 59. Europe Biologics and Biosimilars Sales Market Share by Country in 2020
Figure 60. Europe Biologics and Biosimilars Revenue Market Share by Country in 2020
Figure 61. Europe Biologics and Biosimilars Sales Market Share by Type in 2020
Figure 62. Europe Biologics and Biosimilars Sales Market Share by Application in 2020
Figure 63. Germany Biologics and Biosimilars Revenue Growth 2016-2021 ($ Millions)
Figure 64. France Biologics and Biosimilars Revenue Growth 2016-2021 ($ Millions)
Figure 65. UK Biologics and Biosimilars Revenue Growth 2016-2021 ($ Millions)
Figure 66. Italy Biologics and Biosimilars Revenue Growth 2016-2021 ($ Millions)
Figure 67. Russia Biologics and Biosimilars Revenue Growth 2016-2021 ($ Millions)
Figure 68. Middle East & Africa Biologics and Biosimilars Sales Market Share by Country in 2020
Figure 69. Middle East & Africa Biologics and Biosimilars Revenue Market Share by Country in 2020
Figure 70. Middle East & Africa Biologics and Biosimilars Sales Market Share by Type in 2020
Figure 71. Middle East & Africa Biologics and Biosimilars Sales Market Share by Application in 2020
Figure 72. Egypt Biologics and Biosimilars Revenue Growth 2016-2021 ($ Millions)
Figure 73. South Africa Biologics and Biosimilars Revenue Growth 2016-2021 ($ Millions)
Figure 74. Israel Biologics and Biosimilars Revenue Growth 2016-2021 ($ Millions)
Figure 75. Turkey Biologics and Biosimilars Revenue Growth 2016-2021 ($ Millions)
Figure 76. GCC Country Biologics and Biosimilars Revenue Growth 2016-2021 ($ Millions)
Figure 77. Channels of Distribution
Figure 78. Distributors Profiles
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
